BGI Group has been at the forefront in the fight against COVID-19. Starting from building a lab in Wuhan, sequencing the first 2019-nCoV virus genome and offering RT-PCR and sequencing-based detection solutions. This webinar will present details of the BGI workflows for qPCR and sequencing that have been deployed in over 60 countries and have performed over 1,000,000 tests.

As the subsidiary of BGI Group that focuses on building core tools and technology to lead life science through intelligent innovation, MGI offers a live webinar explaining MGI’s automation for extraction and high throughput sequencing solution for COVID-19 and the steps needed for accurate laboratory detection.

Our total solution includes one-stop nucleic acid extraction and high-throughput sequencing. We describe the role of both RT-PCR and Massively Parallel Sequencing in accurately detecting and tracking coronavirus cases.

Extraction kits, automation systems, and sequencers are for Research Use Only in the US.